Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and T-Lymphocytopenia, Idiopathic CD4-Positive

lenalidomide has been researched along with T-Lymphocytopenia, Idiopathic CD4-Positive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deeks, SG; Ferrucci, L; Goetzl, EJ; Greig, N; Hesdorffer, CS; Kane, L; Lim, H; Schwartz, JB1

Other Studies

1 other study(ies) available for lenalidomide and T-Lymphocytopenia, Idiopathic CD4-Positive

ArticleYear
Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)-infected and HIV-negative CD4 T lymphocytopenic patients.
    Clinical and experimental immunology, 2012, Volume: 169, Issue:2

    Topics: Adult; CD4-CD8 Ratio; Chemotaxis; HIV Infections; Humans; Interleukin-2; Lenalidomide; Male; Middle Aged; T-Lymphocytes; T-Lymphocytopenia, Idiopathic CD4-Positive; Thalidomide

2012